RSS feed
Posts Tagged ‘
Crucell
’Vaccines give a boost to pharma M&A
A recent flurry of deals in the pharmaceutical sector highlights what savvy investors have known for some time — vaccines are the new M&A targets.
The Wall Street Journal notes on Monday that the recent health scares over global pandemics and the growing involvement of governments in purchasing vaccines en masse have become key driving forces in the thriving world of pharma M&A.
J&J buys 18% stake in Crucell
Johnson & Johnson signalled its diversification into vaccines on Monday with an equity and investment deal in excess of €302m ($442m) in Crucell that could secure it control of the world’s first universal flu jab.